Extracellular RNA in kidney disease: Moving slowly but surely from bench to bedside

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

We have known for just over a decade that functional RNA is shuttled between cells (Nat. Cell Biol. (2007) 9, 654–659). In that short time, there have been countless reports of extracellular RNA (exRNA) and extracellular vesicles (EVs) participating in diverse biological processes in development (Dev. Cell (2017) 40, 95–103), homoeostasis (Nature (2017) 542, 450–455) and disease (Nature (2017) 546, 498–503). Unsurprisingly – as these disciplines are still in their infancies – most of this work is still in the ‘discovery biology’ phase. However, exRNA and EVs show promise as disease biomarkers and could be harnessed in novel therapies.

Cite

CITATION STYLE

APA

Hunter, R. W., & Dhaun, N. (2020, November 1). Extracellular RNA in kidney disease: Moving slowly but surely from bench to bedside. Clinical Science. Portland Press Ltd. https://doi.org/10.1042/CS20201092

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free